#COMIRNATY

Around early December I started writing a lot about problems w the EU vaccination strategy. Judging by the reactions, it felt like it was the most controversial opinion I've ever
Read more
BREAKING—Trump FDA just left final kick in the teeth—Pfizer will now ship fewer #COVID19 vaccine vials after it lobbied to count & **pay for** “extra” doses found in vials. Now
Read more
What I feel the Indian #CovidVaccine #vaccinations scene will be likeGovernment will used Oxford - AstraZeneca's #Covishield initially as the lead vaccine it is public vaccination program.Eventually, I expect #Covaxin
Read more
Bila ada 'Dr' depan nama, dan lebih 35,000 follower di Instagram, berhati-hati lah dengan apa yang diperkatakan di akaun tersebut. Jika pemahaman dan penyampaian salah, ini lah akibatnya.https://twitter.com/runandlost/status/1362453
Read more
It's getting hard to keep up with all the vaccine-related news, so I tried summarizing key developments (with a focus on European supplies) from just the past week: 1, Very
Read more
[THREAD]La #vaccination contre la #COVID19 débute avec le #vaccin Comirnaty de Pfizer/BioNTech. Ce vaccin est il sûr ?Ça veut dire quoi au juste ? Comirnaty est un vaccin à
Read more
It is increasingly clear that the EU vaccine supply problems have bottomed out and that the news will be considerably better going forward. This shifts the "vaccine delivery problem" firmly
Read more
FANTASTIC NEWS—A potential vaccine for multiple sclerosis is now within sight on the horizon! And it’s an mRNA vaccine by BioNTech, maker of the Pfizer #COVID19 vaccine. Study in mice
Read more
1. CHYNA will be manufacturing and supplying the vaccine!~ Pfiser is working with BioNTech who produced the vaccine~ BioNTech signed an agreement with Shanghai Fosum giving them manufacturing rights to
Read more
NOT GOOD—so it seems government researchers have discovered that the already more contagious #B117 has further acquired the other troublesome E484K mutation seen in #B1351 & #P1 variants—in 11
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.